IAEDP CERTIFICATION EXAM STUDY
GUIDE QUESTIONS WITH 100%
COMPLETE SOLUTIONS| LATEST UPDATE
Medications increasing cardiac QT interval - correct answer-Abilify, Zofran, Reglan,
Lamictal
Bone resorption in AN - correct answer-Estrogen/Progesterone deficiency
Potassium and Phosphorous monitoring - correct answer-True
Zyprexa (Olanzapine) side effects - correct answer-Increase appetite, weight, diabetes,
ketosis, increase cholesterol, triglycerides
Metabolic Alkalosis - correct answer-Most common metabolic imbalance in BN
Bone density monitoring - correct answer-Annually
Refeeding Syndrome risk factors - correct answer-Weight less than 70% of expected
weight, not eating for 7 or more days, tube feeding
Carotenemia - correct answer-Purple coloring of the skin in AN
Potassium and Phosphorous monitoring - correct answer-True
Lab finding in patients with AN - correct answer-Mildly elevated AST, ALT
Bone loss prevention - correct answer-True
Refeeding Syndrome - correct answer-Hypophosphatemia, heart failure, seizure, death
, Metabolic acidosis - correct answer-True
Hypokalemia symptoms - correct answer-Palpitations, cardiac arrhythmia
Refeeding hypophosphatemia - correct answer-Most common complication of refeeding
malnourished patient
Medications increasing cardiac QT interval - correct answer-Abilify, Zofran, Reglan,
Lamictal
Bone resorption in AN - correct answer-Estrogen/Progesterone deficiency
Potassium and Phosphorous monitoring - correct answer-True
Zyprexa (Olanzapine) side effects - correct answer-Increase appetite, weight, diabetes,
ketosis, increase cholesterol, triglycerides
Metabolic Alkalosis - correct answer-Most common metabolic imbalance in BN
Bone density monitoring - correct answer-Annually
Refeeding Syndrome risk factors - correct answer-Weight less than 70% of expected
weight, not eating for 7 or more days, tube feeding
Carotenemia - correct answer-Purple coloring of the skin in AN
Potassium and Phosphorous monitoring - correct answer-True
Lab finding in patients with AN - correct answer-Mildly elevated AST, ALT
Bone loss prevention - correct answer-True
GUIDE QUESTIONS WITH 100%
COMPLETE SOLUTIONS| LATEST UPDATE
Medications increasing cardiac QT interval - correct answer-Abilify, Zofran, Reglan,
Lamictal
Bone resorption in AN - correct answer-Estrogen/Progesterone deficiency
Potassium and Phosphorous monitoring - correct answer-True
Zyprexa (Olanzapine) side effects - correct answer-Increase appetite, weight, diabetes,
ketosis, increase cholesterol, triglycerides
Metabolic Alkalosis - correct answer-Most common metabolic imbalance in BN
Bone density monitoring - correct answer-Annually
Refeeding Syndrome risk factors - correct answer-Weight less than 70% of expected
weight, not eating for 7 or more days, tube feeding
Carotenemia - correct answer-Purple coloring of the skin in AN
Potassium and Phosphorous monitoring - correct answer-True
Lab finding in patients with AN - correct answer-Mildly elevated AST, ALT
Bone loss prevention - correct answer-True
Refeeding Syndrome - correct answer-Hypophosphatemia, heart failure, seizure, death
, Metabolic acidosis - correct answer-True
Hypokalemia symptoms - correct answer-Palpitations, cardiac arrhythmia
Refeeding hypophosphatemia - correct answer-Most common complication of refeeding
malnourished patient
Medications increasing cardiac QT interval - correct answer-Abilify, Zofran, Reglan,
Lamictal
Bone resorption in AN - correct answer-Estrogen/Progesterone deficiency
Potassium and Phosphorous monitoring - correct answer-True
Zyprexa (Olanzapine) side effects - correct answer-Increase appetite, weight, diabetes,
ketosis, increase cholesterol, triglycerides
Metabolic Alkalosis - correct answer-Most common metabolic imbalance in BN
Bone density monitoring - correct answer-Annually
Refeeding Syndrome risk factors - correct answer-Weight less than 70% of expected
weight, not eating for 7 or more days, tube feeding
Carotenemia - correct answer-Purple coloring of the skin in AN
Potassium and Phosphorous monitoring - correct answer-True
Lab finding in patients with AN - correct answer-Mildly elevated AST, ALT
Bone loss prevention - correct answer-True
